SOST and sclerosteosis: The clinical, biochemical, and radiological features of sclerosteosis and van Buchem disease have been described in detail [23–31] and we will further discuss only features of these diseases that may assist in the interpretation of results obtained in preclinical and clinical studies of sclerostin inhibition.